Clinical Pharmacokinetics of the Newer ACE Inhibitors
- 1 September 1990
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 19 (3) , 177-196
- https://doi.org/10.2165/00003088-199019030-00003
Abstract
The orally active angiotensin-converting inhibitors (ACE inhibitors) such as captopril and enalapril represent a significant therapeutic advance in the treatment of hypertension and congestive heart...Keywords
This publication has 96 references indexed in Scilit:
- Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populationsAmerican Heart Journal, 1989
- Angiotensin-Converting Enzyme InhibitorsClinical Pharmacokinetics, 1988
- Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteersEuropean Journal of Clinical Pharmacology, 1988
- Pentopril‐Cimetidine Interaction Caused by a Reduction in Hepatic Blood FlowThe Journal of Clinical Pharmacology, 1988
- A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor.Journal of Pharmacobio-Dynamics, 1988
- Multiple‐dose Cimetidine Administration Does Not Influence the Single‐dose Pharmacokinetics of Quinapril and Its Active Metabolite (CI‐928)The Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal functionEuropean Journal of Clinical Pharmacology, 1988
- Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patientsThe American Journal of Cardiology, 1987
- Competitive Inhibitor Binding Assay (CIBA) of ACE InhibitorsActa Medica Scandinavica, 1986
- Clinical Pharmacokinetics of the Angiotensin Converting Enzyme Inhibitors A ReviewClinical Pharmacokinetics, 1985